Advertisement

Topics

Latest Immunization NewsRSS

11:39 EST 13th November 2018 | BioPortfolio

How Deady Pneumococcus Avoids Immune Defenses

NewsScientists have discovered a new and important function of a toxin that could have significant implications for future vaccine design.

ImmunoRestoration, Inc. Announces IND Transfer Completed

HER-2 Pulsed DC Vaccine ImmunoRestoration, Inc., a biotech recently formed to lead the development and commercialization of a novel immunotherapeutic cancer cell therapy platform, announces the receipt of the previously held Investigator IND, BB-IND-11043 from Dr. Brian Czerniecki, MD., Ph.D, of the H. Lee Moffitt Cancer Center & Research Institute...

China proposes new laws on vaccine management https://reut.rs/2QBZEii 

China proposes new laws on vaccine management https://reut.rs/2QBZEii 

Adimmune Corp 4142 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryAdimmune Corp Adimmune is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation's products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provides therapeutic nucleic acids, influenza vaccine, entrovirus 71 vaccine, and Japanese encephalitis vaccin...

$MRNA One of Moderna's CMV vaccine candidate "did not meet internal quality control specifications for visual inspection after one year of storage" Briefly on FDA clinical hold, but lifted within two days, that's probably a new record?pic.twitter.com/HZi

$MRNA One of Moderna's CMV vaccine candidate "did not meet internal quality control specifications for visual inspection after one year of storage" Briefly on FDA clinical hold, but lifted within two days, that's probably a new record? pic.twitter.com/HZicM1MY3p

High dose flu vaccine improves immune response for people with rheumatoid arthritis – new study

The use of a high-dose trivalent inactivated flu vaccine seems to improve immune response in people with rheumatoid arthritis better than the standard-dose quadrivalent inactivated vaccine, according to data presented at an international conference. “People living with rheumatoid arthritis have an increased risk for influenza infection and influenza-related illness,” explained Dr Ines Colmegna...

NantKwest Gets A Shot In The Arm, CPRX Awaits FDA Word, FOMX Meets Phase 3 Goals

Today's Daily Dose brings you news about the near-term catalysts of Catalyst Pharma; progress in Entasis' gonorrhea study; positive results of Foamix Pharma's phase III papulopustular rosacea studies; Lannett's revised revenue outlook; NantKwest's cancer vaccine trial results; Nu Skin Enterprises' Q3 financial results and Rennova Health's reverse stock split.

First Potential Vaccine for Chikungunya Virus Flies Through Phase II

The mosquito-borne chikungunya virus may one day have a vaccine, as an Austrian biotech’s lead candidate gets positive results in Phase II. Themis Bioscience measured the blood levels of antibodies against the company’s vaccine in 263 healthy volunteers. Four weeks ... The post First Potential Vaccine for Chikungunya Virus Flies Through Phase II appeared first on Labiotech.eu.

Anti-D 50th Anniversary Celebration Held on Nov. 1, 2018: 1st Annual International Meeting for Global Eradication of Rh Disease

Before 1968, hemolytic disease of the newborn (HDFN) claimed the lives of 10,000 infants per year in the U.S. alone; since then, this easily preventable condition has virtually disappeared from the United States, Canada, Western Europe, and Australia thanks to the discovery and regulatory approval of Rh immunoglobulin (RhIG), also called ...

NantKwest Announces Multiple Presentations at the 2018 Society for Immunotherapy of Cancer Conference

Update on Off-The-Shelf CD16 Targeted NK Cell (haNK) and NANT Cancer Vaccine Program Including Interim Data Analysis for Pancreatic Cancer, Triple Negative Breast Cancer & Head and Neck Cancer Trials NantKwest (NASDAQ: NK), a leading, clinical-stage natural killer cell-based therapeutics company, today announced that the company will be m...

Merck Halts Supply of Lifesaving Vaccine for African Kids to Seek Greater Profits in China, US, Says AHF

AHF condemns Merck for cutting off lifesaving vaccine for children dying from diarrhea in Africa while it also announces plans to expand distribution—and far more lucrative sales—in China AIDS Healthcare Foundation (AHF) today sharply criticized U.S. pharmac

Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet

--MV-CHIK met the primary endpoint, eliciting a potent immune response as measured by induction of neutralizing antibodies against Chikungunya, in all treatment groups-- --Up to 100% seroconversion rate achieved after two injections-- --Excellent safety and tolerability profile demonstrated-- Themis Bioscience announced today t...

Curevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate

SEATTLE and YONGIN, South Korea, Nov. 5, 2018 /PRNewswire/ -- Curevo, a Seattle-based biotechnology company owned by GC Pharma, one of the largest therapeutic protein manufacturers in the world, announced today that the U.S. Food and Drug Administration (FDA) has advanced the company's Investigational New Drug (IND) application for CRV-101. The vaccine candidate for the prevention of herpes zoster...

Flu vaccinations in community pharmacies approach 850,000

Community pharmacists in England have administered the flu vaccine to at least 840,472 people so far this this season, according to figures collated from electronic registers by the Pharmaceutical Services Negotiating Committee.

Immunocompromised Patients Could Get Help from New #Vaccine Strategy: http://ow.ly/dhvb30mpFrk pic.twitter.com/LJzGqqEjLl

Immunocompromised Patients Could Get Help from New #Vaccine Strategy: http://ow.ly/dhvb30mpFrk  pic.twitter.com/LJzGqqEjLl

Merck is rolling back its commitment to provide a life-saving rotavirus vaccine to parts of West Africa at the same time the drug maker is ramping up supplies to #China, where the product would reportedly be sold for a much higher price. https://buff.ly/2

Merck is rolling back its commitment to provide a life-saving rotavirus vaccine to parts of West Africa at the same time the drug maker is ramping up supplies to #China, where the product would reportedly be sold for a much higher price. https://buff.ly/2SzHkaZ 

A Llama Antibody Could Be the Key to a Universal Flu Vaccine

Less than a week ago, Roche snagged regulatory approval for Xofluza, a single-dose oral medication, the first new flu treatment approved in 20 years. Now, new research indicates that llamas, the doe-eyed South American pack animal, may hold the key to flu vaccines.

In a controversial move, Merck is rolling back its commitment to provide a life-saving rotavirus vaccine to parts of West Africa at the same time the drug maker is ramping up supplies to #China. https://buff.ly/2Jx42w7 

In a controversial move, Merck is rolling back its commitment to provide a life-saving rotavirus vaccine to parts of West Africa at the same time the drug maker is ramping up supplies to #China. https://buff.ly/2Jx42w7 

Merck cuts back on vaccine commitment to West Africa as shipments to China ramp up

In a controversial move, Merck is rolling back its commitment to provide a life-saving rotavirus vaccine to parts of West Africa at the same time the drug maker is ramping…

CDC Updates Guidelines on Pre- and Postexposure Protection Against Hepatitis A

The CDC has published its latest guidance on pre- and postexposure prophylaxis with hepatitis A vaccine or immune globulin in MMWR. For postexposure protection, the...

Universal flu vaccine candidate demonstrates preclinical success

InvVaxâs universal flu vaccine candidate has demonstrated preclinical success as the company prepares for a Phase I clinical trial, supported by a Series A fundraising round.

STAT Plus: Pharmalittle: FDA to speed review of controversial dengue vaccine; Allergan disappoints investors

The Food and Drug Administration has agreed to a priority review for the controversial dengue vaccine made by Sanofi.

Shingles vaccine helps GSK shrug off Advair threat

GSK’s shingles vaccine helps it shrug off Advair fears

UK drugmaker tightens full-year guidance towards upper end of expectations

Now's a Good Time to Get Your Flu Vaccine

Early in the fall is the best time to get your annual flu vaccine. Find out why it's important to get one.

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Immunization market research data and corporate reports here